Skip to main content

Table 5 Secondary outcome measures (Repeated versus new prescribing)

From: A cluster randomised stepped wedge trial to evaluate the effectiveness of a multifaceted information technology-based intervention in reducing high-risk prescribing of non-steroidal anti-inflammatory drugs and antiplatelets in primary medical care: The DQIP study protocol

Number Risk factor (Denominator) High-risk prescription definition (Numerator)
CPO- Repeated Number of patients with any risk factor listed in PO-measures 1 to 9 (Table 4) Number of patients with any high-risk prescription listed in PO- measures 1 to 9 (Table 4) where the patient has received a high-risk prescription in the previous 12 months
CPO-New Number of patients with any risk factor listed in PO-measures 1 to 9 (Table 4) Number of patients with any high-risk prescription listed in PO-measures 1 to 9 (Table 4) where the patient has NOT received a high-risk prescription in the previous 12 months